Global Information
회사소개 | 문의 | 비교리스트

세계의 치료용 혈장교환 시장 예측과 기회(2025년)

Global Therapeutic Plasma Exchange Market By Technique, By Indication, By Gender, By End Use, By Region, Forecast & Opportunities, 2025

리서치사 TechSci Research
발행일 2020년 05월 상품 코드 934763
페이지 정보 영문 112 Pages
가격
US $ 4,450 ₩ 5,088,000 Unprintable PDF and Excel (Single User License)
US $ 5,450 ₩ 6,231,000 PDF and Excel (Multi-User License)
US $ 9,450 ₩ 10,805,000 PDF and Excel (Custom Research License)

TechSci Research 보고서는 10% Customization 서비스가 포함되어 있습니다. 보고서에 포함돼 있지 않은 리서치 데이터와 시장 동향을 추가적으로 요청할 수 있습니다. 자세한 사항은 문의하여 주시기 바랍니다.



세계의 치료용 혈장교환 시장 예측과 기회(2025년) Global Therapeutic Plasma Exchange Market By Technique, By Indication, By Gender, By End Use, By Region, Forecast & Opportunities, 2025
발행일 : 2020년 05월 페이지 정보 : 영문 112 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 치료용 혈장교환(Therapeutic Plasma Exchange) 시장은 예측 기간 중 활발한 속도로 성장할 것으로 예측되고 있습니다. 치료용 혈장교환 또는 혈장분리교환술(plasmapheresis)은 원심분리 또는 막분리로 불리는 기술의 지원으로 혈액으로부터 혈장을 분리하는 것으로, 혈액을 여과하고 혈장중 존재하는 유해한 항체를 제거하는 수술입니다. 체내 혈액을 교환하는 프로세스인 치료용 혈장교환 또는 혈장교환 요법은 만성질환의 증가에 수반하는 수요의 대폭적인 증가를 목격하고 있습니다. 예를 들면 길랭-바레 증후군(GBS) 등입니다. 이것에 의해 전 세계의 혈장교환 시장에 플러스 영향을 미치고 있습니다. 그러나 혈장교환 요법은 비용이 소요되므로 시장의 성장을 저해할 가능성이 있습니다.

세계의 치료용 혈장교환 시장은 기술별, 적응별, 성별, 최종 용도별, 지역별로 세분화되어 있습니다. 적응별로는 신경장애, 신장 장애, 혈액 장애, 대사장애로 분류되며, 만성·치명적인 신경장애의 증례 수가 매일 증가하는 가운데 신경장애가 가장 지배적인 부문이 될 것으로 예상됩니다.

세계의 치료용 혈장교환 시장에 대해 조사분석했으며, 시장 규모·점유율·예측, 부문별 분석, 경쟁 분석, 시장 동향의 변화, 신규 기회에 관한 정보를 정리하여 전해드립니다.

목차

제1장 제품 개요

제2장 조사 방법

제3장 개요

제4장 고객의 소리

제5장 세계의 치료용 혈장교환 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
  • 제품 시장 지도

제6장 아시아태평양의 치료용 혈장교환 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
  • 아시아태평양 : 국가별 분석

제7장 유럽의 치료용 혈장교환 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
  • 유럽 : 국가별 분석

제8장 북미의 치료용 혈장교환 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
  • 북미 : 국가별 분석

제9장 남미의 치료용 혈장교환 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
  • 남미 : 국가별 분석

제10장 중동·아프리카의 치료용 혈장교환 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
  • 중동·아프리카 : 국가별 분석

제11장 시장 역학

  • 촉진요인
  • 과제

제12장 시장 동향과 개발

제13장 경쟁 구도

제14장 전략적 제안

제15장 출판사와 면책사항

KSA 20.05.27

The global market for therapeutic plasma exchange is anticipated to grow at brisk rate during the forecast period. Therapeutic plasma exchange or plasmapheresis is a procedure to filter blood and remove harmful antibodies present in plasma by separating it from blood with the assistance of techniques called centrifugation or membrane separation. Therapeutic plasma exchange or Plasmapheresis, the process of replacing blood in the body, has witnessed significant rise in demand on account of increasing chronic diseases, for instance, Guillain Barre Syndrome (GBS); thereby, positively influencing the therapeutic plasma exchange market across the globe. However, plasmapheresis is costly enough, which is expected to hamper the growth of the market.

Global therapeutic plasma exchange market is segmented on the basis of technique, indication, gender, end use and region. Indication segment is further divided into neurological disorders, renal disorders, hematology disorders, metabolic disorders, out of which, neurological disorders is expected to be the most dominant segment as the number of cases of chronic and fatal neurological disorders are increasing day by day.

North America held the largest market share in the year of 2019 due to the pre-existing pharma & biotech companies and the surge in research and development activities in the region. On the other hand, Asia-Pacific is expected to be the fastest growing region as the leading companies of therapeutic plasma exchange in the region have now started investing in the plasmapheresis procedures.

Haemonetics Corporation, Fresenius Medical Care, Terumo BCT, Inc., Baxter International Inc., Asahi Kasei Medical Co., Ltd., Kawasumi Laboratories Inc., B. Braun Melsungen AG, HemaCare Corporation, Medica S.p.A., Cerus Corporation, Nikkiso Co., Ltd., Miltenyi Biotec, Therakos Incorporation, Fenwal Incorporation, Kaneka Corporation, etc., are some of the prominent therapeutic plasma exchange companies of the world. To maintain their position in the global therapeutic plasma exchange market, the leading players are adopting several organic and inorganic strategies such as mergers, acquisitions, etc.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study

  • To analyze and estimate the market size of global therapeutic plasma exchange market from 2015 to 2018.
  • To estimate and forecast the market size of global therapeutic plasma exchange market from 2019 to 2025 and growth rate until 2025.
  • To classify and forecast global therapeutic plasma exchange market based on technique, indication, gender, end use, company and region.
  • To identify dominant region or segment in the global therapeutic plasma exchange market.
  • To identify drivers and challenges for global therapeutic plasma exchange market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global therapeutic plasma exchange market.
  • To conduct pricing analysis for global therapeutic plasma exchange market.
  • To identify and analyze the profile of leading players operating in global therapeutic plasma exchange market.
  • To identify key sustainable strategies adopted by market players in global therapeutic plasma exchange market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of hospitals and clinics using therapeutic plasma exchange techniques across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the hospitals and clinics using therapeutic plasma exchange techniques which could not be identified due to the limitations of secondary research. TechSci Research analyzed the hospitals and clinics using therapeutic plasma exchange techniques, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global therapeutic plasma exchange market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience

  • Hospitals, clinics, research organizations and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to therapeutic plasma exchange
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals and clinics using therapeutic plasma exchange techniques, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope

In this report, global therapeutic plasma exchange market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Technique:

Centrifugation

Membrane Separation

  • Market, By Indication:

Neurological Disorders

Renal Disorders

Hematology Disorders

Metabolic Disorders

  • Market, By Gender:

Male

Female

  • Market, By End Use:

Hospitals

Clinics

Others

  • Market, By Region:

Asia-Pacific

  • China
  • India
  • Australia
  • Japan
  • South Korea

Europe

  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain

North America

  • United States
  • Mexico
  • Canada

South America

  • Brazil
  • Argentina
  • Colombia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global therapeutic plasma exchange market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

  • 4.1. Brand Awareness (Aided/Unaided)
  • 4.2. Product Awareness
  • 4.3. Customer Satisfaction Analysis
  • 4.4. Unmet Needs/Challenges

5. Global Therapeutic Plasma Exchange Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Technique (Centrifugation v/s Membrane Separation)
    • 5.2.2. By Indication (Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders)
    • 5.2.3. By Gender (Male v/s Female)
    • 5.2.4. By End Use (Hospitals, Clinics, Others)
    • 5.2.5. By Company (2019)
    • 5.2.6. By Region
  • 5.3. Product Market Map

6. Asia-Pacific Therapeutic Plasma Exchange Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technique
    • 6.2.2. By Indication
    • 6.2.3. By End Use
    • 6.2.4. By Country
  • 6.3. Asia-Pacific: Country Analysis
    • 6.3.1. China Therapeutic Plasma Exchange Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Technique
        • 6.3.1.2.2. By Indication
        • 6.3.1.2.3. By End Use
    • 6.3.2. India Therapeutic Plasma Exchange Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Technique
        • 6.3.2.2.2. By Indication
        • 6.3.2.2.3. By End Use
    • 6.3.3. Australia Therapeutic Plasma Exchange Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Technique
        • 6.3.3.2.2. By Indication
        • 6.3.3.2.3. By End Use
    • 6.3.4. Japan Therapeutic Plasma Exchange Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Technique
        • 6.3.4.2.2. By Indication
        • 6.3.4.2.3. By End Use
    • 6.3.5. South Korea Therapeutic Plasma Exchange Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Technique
        • 6.3.5.2.2. By Indication
        • 6.3.5.2.3. By End Use

7. Europe Therapeutic Plasma Exchange Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technique
    • 7.2.2. By Indication
    • 7.2.3. By End Use
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Therapeutic Plasma Exchange Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Technique
        • 7.3.1.2.2. By Indication
        • 7.3.1.2.3. By End Use
    • 7.3.2. Germany Therapeutic Plasma Exchange Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Technique
        • 7.3.2.2.2. By Indication
        • 7.3.2.2.3. By End Use
    • 7.3.3. United Kingdom Therapeutic Plasma Exchange Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Technique
        • 7.3.3.2.2. By Indication
        • 7.3.3.2.3. By End Use
    • 7.3.4. Italy Therapeutic Plasma Exchange Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Technique
        • 7.3.4.2.2. By Indication
        • 7.3.4.2.3. By End Use
    • 7.3.5. Spain Therapeutic Plasma Exchange Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Technique
        • 7.3.5.2.2. By Indication
        • 7.3.5.2.3. By End Use

8. North America Therapeutic Plasma Exchange Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technique
    • 8.2.2. By Indication
    • 8.2.3. By End Use
    • 8.2.4. By Country
  • 8.3. North America: Country Analysis
    • 8.3.1. United States Therapeutic Plasma Exchange Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Technique
        • 8.3.1.2.2. By Indication
        • 8.3.1.2.3. By End Use
    • 8.3.2. Mexico Therapeutic Plasma Exchange Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Technique
        • 8.3.2.2.2. By Indication
        • 8.3.2.2.3. By End Use
    • 8.3.3. Canada Therapeutic Plasma Exchange Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Technique
        • 8.3.3.2.2. By Indication
        • 8.3.3.2.3. By End Use

9. South America Therapeutic Plasma Exchange Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technique
    • 9.2.2. By Indication
    • 9.2.3. By End Use
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Therapeutic Plasma Exchange Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Technique
        • 9.3.1.2.2. By Indication
        • 9.3.1.2.3. By End Use
    • 9.3.2. Argentina Therapeutic Plasma Exchange Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Technique
        • 9.3.2.2.2. By Indication
        • 9.3.2.2.3. By End Use
    • 9.3.3. Colombia Therapeutic Plasma Exchange Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Technique
        • 9.3.3.2.2. By Indication
        • 9.3.3.2.3. By End Use

10. Middle East and Africa Therapeutic Plasma Exchange Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Technique
    • 10.2.2. By Indication
    • 10.2.3. By End Use
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Therapeutic Plasma Exchange Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Technique
        • 10.3.1.2.2. By Indication
        • 10.3.1.2.3. By End Use
    • 10.3.2. Saudi Arabia Therapeutic Plasma Exchange Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Technique
        • 10.3.2.2.2. By Indication
        • 10.3.2.2.3. By End Use
    • 10.3.3. UAE Therapeutic Plasma Exchange Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Technique
        • 10.3.3.2.2. By Indication
        • 10.3.3.2.3. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

13. Competitive Landscape

  • 13.1. Haemonetics Corporation
  • 13.2. Fresenius Medical Care
  • 13.3. Terumo BCT, Inc.
  • 13.4. Baxter International Inc.
  • 13.5. Asahi Kasei Medical Co., Ltd.
  • 13.6. Kawasumi Laboratories Inc.
  • 13.7. B. Braun Melsungen AG
  • 13.8. HemaCare Corporation
  • 13.9. Medica S.p.A.
  • 13.10. Cerus Corporation
  • 13.11. Nikkiso Co., Ltd.
  • 13.12. Miltenyi Biotec
  • 13.13. Therakos Incorporation
  • 13.14. Fenwal Incorporation
  • 13.15. Kaneka Corporation

14. Strategic Recommendations

15. About Us & Disclaimer

Back to Top
전화 문의
F A Q